In Crustacea, an early evolutionary group (;50 000 species) inhabiting most ecological niches, sex differentiation is regulated by a male-specific androgenic gland (AG). The identification of AG-specific insulin-like factors (IAGs) and genomic sex markers offers an opportunity for a deeper understanding of the sexual differentiation mechanism in crustaceans and other arthropods. Here, we report, to our knowledge, the first full and functional sex reversal of male freshwater prawns (Macrobrachium rosenbergii) through the silencing of a single IAGencoding gene. These ''neofemales'' produced all-male progeny, as proven by sex-specific genomic markers. This finding offers an insight regarding the biology and evolution of sex differentiation regulation, with a novel perspective for the evolution of insulinlike peptides. Our results demonstrate how temporal intervention with a key regulating gene induces a determinative, extreme phenotypic shift. Our results also carry tremendous ecological and commercial implications. Invasive and pest crustacean species represent genuine concerns worldwide without an apparent solution. Such efforts might, therefore, benefit from sexual manipulations, as has been successfully realized with other arthropods. Commercially, such manipulation would be significant in sexually dimorphic cultured species, allowing the use of nonbreeding, monosex populations while dramatically increasing yield and possibly minimizing the invasion of exotic cultured species into the environment.
INTRODUCTION
The archaic group of Crustacea includes approximately 50 000 species inhabiting most ecological niches. The underlying mechanism regulating sexual differentiation in this varied group goes through the male-specific androgenic gland (AG) [1] . In the giant freshwater prawn (Macrobrachium rosenbergii), a full functional sex reversal has been achieved by removal [2] of the AG from juvenile males to obtain ''neofemales'' and transplantation [3] of the AG to juvenile females to obtain ''neomales.'' In a few other decapod species, as well as in some isopod and amphipod species, such surgical interventions caused a sexual shift [4] .
The identification of AG-specific insulin-like factors (IAGs) [4] and genomic sex markers [5] in crustaceans offers an opportunity for a deeper understanding of the sexual differentiation mechanism in crustaceans and other arthropods. Previous findings revealed that M. rosenbergii IAG (Mr-IAG) is critical for spermatogenesis and the appearance of external sexual characteristics [6] through its silencing in mature males. These results placed Mr-IAG as a leading candidate for being an androgenic hormone. Since then, molecular sex markers identified for the first time in M. rosenbergii [5] enabled tracing of the genetically set gender before the appearance of any external sexual characteristics. This finding was followed by a detailed examination of the temporal expression pattern of Mr-IAG, revealing it starts to express approximately 20 days after metamorphosis (Postlarval Day [PLD] 20), before any documented sexual characteristic in crustaceans [7] . This result further supports the hypothesis according to which Mr-IAG is an AG hormone that not only governs the maintenance of male sexual characteristics during adulthood but also dictates early male sexual differentiation. Therefore, we aimed to achieve a full functional sex reversal of males into neofemales through silencing Mr-IAG earlier than the appearance of external sexual characteristics. This was feasible by applying genomic sex markers to identify juvenile males (PLD 20-30; see Materials and Methods).
Here, we report, to our knowledge, the first full functional sex reversal of males through the silencing of a single IAG-encoding gene. These neofemales produced all-male progeny, as proven by sex-specific genomic markers. This finding offers an insight regarding the biology and evolution of sex differentiation regulation, with a novel perspective for the evolution of insulin-like peptides. Our results demonstrate how temporal intervention with a key regulating gene induces a determinative, extreme phenotypic shift. Our results also carry tremendous ecological and commercial implications. Invasive and pest crustacean species represent genuine concerns worldwide without an apparent solution [8] . Such efforts might, therefore, benefit from sexual manipulations, as has been successfully realized with other arthropods [9] . Commercially, such manipulation would be significant in sexually dimorphic cultured species, allowing the use of nonbreeding monosex populations while dramatically increasing yield and possibly minimizing the invasion of exotic cultured species into the environment.
MATERIALS AND METHODS

Animals
Macrobrachium rosenbergii were maintained at Ben-Gurion University of the Negev under the following conditions: Food comprising shrimp pellets (30% protein; Rangen) was supplied ad libitum three times a week. Water quality was assured by circulating the entire volume through a biofilter maintaining all the required water physicochemical parameters as described previously [10] . Egg-bearing females were separately transferred to closed, 100-L tanks containing 12-16 ppt salt water, which was circulated through a 100-lm mesh net. After hatching had occurred, the females were removed from the tanks, and the newly hatched larvae were maintained according to the protocol devised by Uno and Chin Soo [11] and fed with Artemia nauplii daily.
Double-Stranded RNA Preparation
The dsRNA of the Mr-IAG open reading frame was prepared with a MEGAscript T7 Kit (Ambion) according to the manufacturer's instructions. Quality of dsRNA was assessed on an agarose gel. The dsRNA was maintained at À208C until used as described previously [6] .
In Vivo Mr-IAG Silencing
For the time-dependent silencing experiment, young male prawns (wt, 2.49 6 0.17 g [mean 6 SEM]) were divided into four groups, of which one group (n ¼ 5) was injected once with exogenous Remebee (RB) dsRNA (Beeologics) while the other three groups (n ¼ 4 in each group) were injected once with Mr-IAG dsRNA. The dsRNA quantity was calculated as 5 lg dsRNA/g body wt.
AGs from individuals of each of the three Mr-IAG dsRNA-injected groups were taken for RNA extraction 3 days, 1 wk, and 2 wk after the injection, parallel to AGs taken from RB dsRNA-injected individuals at each time.
For the dose-dependent silencing experiment, young male prawns (wt, 1.89 6 0.21 g) were divided into four groups, of which one group (n ¼ 7) was injected once with RB dsRNA while the other three groups (n ¼ 6 in each group) were injected once with Mr-IAG dsRNA at different quantities as follows: 5, 1, and 0.1 lg dsRNA/g body wt. At 1 wk following injection, AGs were taken for RNA extraction from all individuals.
For the long-term in vivo injections experiment, M. rosenbergii males and females (wt, 30-70 mg; age, PLD 30) were selected according to the presence of the female-specific sex marker in females and its absence in males [5, 7] . The postlarval organisms were assigned to one of three treatment groups: Mr-IAG dsRNA-injected males (n ¼ 19), water-injected control males (n ¼ 15), and water-injected control females (n ¼ 16) with no foreign dsRNA based on Ventura et al. [6] . Each animal was housed in a separate, floating, fenestrated plastic container (3 3 11 cm). Twice a week (over a period of 9 mo), each animal was injected with 5 lg dsRNA/g body wt or a similar volume of water (a total of 71 injections). Molts were recorded twice a week, and weight accumulation was documented. The appearance of male gonopores (MGPs) and appendix masculinae (AM) were viewed under a dissecting stereoscope.
RNA Extraction and Real-Time RT-PCR
The RNA was extracted from the AGs of males used in the time-and dosedependency experiments. Total RNA was isolated with the EZ-RNA Total RNA Isolation Kit (Biological Industries) according to the manufacturer's instructions. First-strand cDNA was synthesized by means of reverse transcriptase reaction using the Verso cDNA Kit (Thermo Fisher Scientific, Inc.) with 1 lg of total RNA. Relative quantification of Mr-IAG transcript levels were obtained using the following primers: 5 0 -GCCTTGCAGT CATCCTTGA-3 0 (IAG qPCR_F) and 5 0 -AGGCCGGAGAGAAGAATGTT-3 0 (IAG qPCR_R) with the FastStart Universal Probe Master (Rox; Roche Diagnostics GmbH) and Universal ProbeLibrary Probe 144 (Roche). Mr-18S (GenBank accession no. GQ131934), which was used as a normalizing gene, was also quantified by means of real-time RT-PCR using the following primers:
0 (qMr-18S_R) with the above-mentioned mix and Universal ProbeLibrary Probe 152 (Roche). Reactions were performed with the ABI Prism 7300 Sequence Detection System (Applied Biosystems).
Tissue Preparation
The AGs from mature male morphotypes were dissected together with the attached terminal ampullae. Tissue samples were fixed in modified Carnoy II for 48 h and dehydrated gradually through a series of increasing alcohol concentrations. Tissues were cleared and embedded in Paraplast (Kendall) according to conventional procedures. Sections (thickness, 5 lm) were cut and mounted onto silane-coated slides (Menzel-Gläser). These slides served for all histological procedures, including immunohistochemistry and in situ hybridization. Before the histological procedures, the slides were deparaffinized in xylene and gradually rehydrated through a series of decreasing alcohol concentrations.
Genomic DNA Extraction and Sex Markers
Genomic DNA was extracted from 2 to 10 mg of 70% ethanol-fixed tissue using a REDExtract-N-Amp Tissue PCR Kit (Sigma) according to the manufacturer's instructions. The genomic sex markers developed in the Israeli line (BGU line) were used as described previously [5] .
PCR of Female-Specific and Positive-Control Sequences
The PCR was performed with 100 ng of genomic DNA, 1 lM forward primer and 1 lM reverse primer (primer sequences available upon request), 12.5 ll of REDTaq ReadyMix (Sigma), and water to a final volume of 25 ll. The PCR conditions used were as follows: 35 cycles of 30 sec at 948C, 30 sec at 568C, and 60 sec at 728C. The PCR products were separated on a 2% agarose gel and visualized under ultraviolet light with ethidium bromide.
Statistical Analysis
The four groups in the real-time RT-PCR were analyzed using the KruskalWallis test followed by the correction of a multiple pair-wise comparison (builtin within the Statistica 6.1 software [StatSoft]) as accepted. To evaluate the effect of dsRNA injections on the rate of MGP and AM appearance, a Cox proportional hazards regression model [12] was used. The model is expressed
, where l(t,z) is the MGP or AM appearance rate and l 0 (t) is the baseline hazard function that can change over time (t). The regression coefficient to be estimated (b i ) represents the independent effect of dsRNA injection on the MGP or AM appearance rate. These analyses were performed with S-PLUS 2000 software (Mathsoft). The effects of dsRNA injection on molt increment and the weight range associated with MGP appearance were statistically analyzed by the nonparametric Mann-Whitney Utest using Statistica software.
RESULTS
Mr-IAG-Silencing: Determination of Effective Time and Dose
Real-time RT-PCR performed on RNA extracted from AGs of individuals injected with Mr-IAG dsRNA (5 lg/g body wt) at different times following the injection showed that Mr-IAG transcript level was significantly reduced compared with the control group after 3 days and 1 wk. After 2 wk, Mr-IAG transcript level did not differ significantly from the control group (Fig. 1A) . Dose dependency was assessed in the same manner. At 1 wk after injection with different doses of Mr-IAG dsRNA (0.1-5 lg/g body wt), real-time RT-PCR showed that 1 lg/g body wt significantly reduced Mr-IAG transcript level compared with the control group, whereas 0.1 lg/g body wt did not (Fig. 1B) .
Mr-IAG-Silencing in Juvenile Males Delays Appearance of Male Sexual Characteristics
In the present study, Mr-IAG silencing caused a delay in the formation of male-specific AM. This delay became significant (P ¼ 0.043, Cox plot hazards model followed by chi-square test) by PLD 128 (Fig. 2A) . By PLD 220, all individuals from the control male group (n ¼ 13, from a starting group of 15) had developed an AM, as compared with as few as 33% of the Mr-IAG-silenced male group (n ¼ 10, from a starting group of 19). None of the control females developed an AM.
The appearance of MGPs was also delayed in the Mr-IAGsilenced group. By PLD 128, this delay became significant (P ¼ 0.032, Cox plot hazards model followed by chi-square test) when compared with the control male group (Fig. 2B) . By PLD 184, both groups included the maximum percentage of individuals with MGPs, and although all individuals developed MGPs in the control male group, only 60% did so in the Mr-IAG-silenced group of males. None of the control females developed MGPs. In control males, MGPs developed in individuals ranging in size from 236 to 546 mg and at times ranging from PLD 124 to PLD 180. In 6 of 10 Mr-IAGsilenced males, MGPs developed in individuals ranging in size from 208 to 271 mg and from PLD 145 to PLD 180. Whereas VENTURA ET AL.
in Mr-IAG-silenced males the time of MGP formation was significantly delayed (Fig. 2B) , it occurred in individuals covering a significantly (P ¼ 0.0033, Mann-Whitney U-test) smaller weight range than seen in the male control group.
Unsuccessful sex reversal attempts were accompanied by delayed formation of male external sexual characteristics (Fig.  2) and hypertrophied AGs in accordance with previously reported results [6] .
Mr-IAG-Silencing in Juvenile Males Induces Ovarian Development
One Mr-IAG-silenced individual (wt, ;800 mg) that did not develop an MGP was sampled for histological survey, whereas the others were injected until they reached a weight of 1 g, along with control males and control females. When the Mr-IAG-silenced individual with no MGP (Fig. 3, middle) was compared with individual male (Fig. 3, left) and female (Fig. 3,  right) controls of the same weight, clear evidence for sex reversal was observed. The Mr-IAG-silenced male resembled the control female, with both having ovaries (Mr-IAG-silenced male and control female shown in Fig. 3 , D and G, respectively, and at higher magnification in Fig. 3 , E and H, respectively) and oviducts (Mr-IAG-silenced male and control female shown in Fig. 3 , F and I, respectively), with no signs of testes, sperm ducts (as evident in the control male; testes shown in Fig. 3, A and B, and sperm duct in Fig. 3C ), or AGs.
Mr-IAG-Silencing in Juvenile Males Induces a Full Functional Sex Reversal into Neofemales
The Mr-IAG-silenced genetic males with no MGP were raised to maturity and developed normal-appearing ovaries (Fig. 4A, top, arrow) as compared with control females (results not shown). These Mr-IAG-silenced genetic males were mated with normal males, and their reproductive behavior was normal and their copulation successful. Specifically, the spermatophore attached by the male onto the ventral cephalothorax of the Mr-IAG-silenced genetic males was maintained. These then spawned and incubated the eggs in their brood chambers, located ventrally on their abdomens (Fig. 4A, bottom, arrow) . These egg-bearing neofemales were transferred to a hatching facility and, in parallel to control females, were hatched. The time of egg development until hatching was similar for the 
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neofemales and the control female progeny (18-20 vs. 15-20 days, respectively), as was the time from hatching to metamorphosis (21-23 days). Larval staging [11] was similar throughout the hatching period. Thirty larvae of zoea stage 3 were sampled from each progeny for genetic sex determination using our molecular sex marker [5] . The genetic sex of the neofemales and control females that produced the progeny was reconfirmed, as was the genetic sex of intact male and female positive controls and a negative control (Fig. 4B, marked as ? , /, and n.c., respectively). All controls and reconfirmations were as expected, revealing the female-specific sex marker only in the intact and control females. The progeny of the control females were found to comprise both males and females, as expected (Fig. 4B, top, F1) , whereas the progeny of the neofemales comprised only males (Fig. 4B, bottom, F1) .
Recently, numerous cases in our laboratory have confirmed that silencing the transcript encoding Mr-IAG in male individuals from PLD 20 caused complete and functional sex reversal into neofemales. When mated with normal males, the neofemale individuals produced all-male populations.
DISCUSSION
We report that silencing the transcript encoding the Mr-IAG in male individuals caused complete and functional sex reversal into neofemales. When mated with normal males, the neofemale individuals produced all-male populations. To our knowledge, this is the first report of a single gene manipulation inducing full functional sex reversal in crustaceans and beyond. Our results demonstrate how temporal intervention with the expression of a sexual differentiation key regulating gene in a certain time frame throughout postmetamorphic juvenile stages indefinitely alters a phenotype in a profound way. Using real-time RT-PCR, Mr-IAG dsRNA injection down to the dose of 0.1 lg dsRNA/g body wt was shown to effectively silence Mr-IAG transcript up to 1 wk (Fig.  1) , longer than the practiced bi/tri-weekly injection regimes with higher doses that were commonly used [6] . Previous reports also show that Mr-IAG silencing inhibits growth [6] , which implicates Mr-IAG as being involved in regulation of metabolism. This result, which was reconfirmed by the present study (data not shown), might explain, in part, the sexually dimorphic growth pattern observed in M. rosenbergii, in which males grow larger and faster than females.
Our results are unique compared with those of other singlegene interventions in the cascade of sexual differentiation, which were performed at earlier stages and did not yield full functional sex reversal [13, 14] . Our results place an insulinlike peptide (Mr-IAG) as a key regulator of sexual differentiation in a crustacean.
In other taxonomic groups, different mechanisms, which do not involve male-specific insulin-like peptides, prevail in the regulation of sexual differentiation. In all vertebrates, an array of peptide and steroidal sex hormones govern the process of sexual differentiation, but with distinctions between and within phyla [15] [16] [17] [18] . Our results suggest an additional viewpoint concerning the evolution of insulin-like peptides, which might   FIG. 4 . Mr-IAG-silencing induces full-functional sex reversal of males into all-male-progeny-producing neofemales. A) Ventral view of a Mr-IAG silenced neofemale incubating eggs in its brood chamber (arrow, with a few eggs magnified). B) Genomic validation of the neofemale and broodstock maleness. PCR products generated from intact male and intact female control individuals and from a control female and individuals from its progeny (top) as templates, as well as the neofemale and individuals from its progeny (bottom), were separated on an agarose gel. F.S., female-specific marker; n.c., negative control; P.C., positive control.
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have emerged in the context of sexual differentiation in the archaic invertebrate group of crustaceans.
Evolutionarily, crustaceans are among the earliest arthropods [19, 20] . In other arthropods, such as insects, mechanisms of sexual differentiation are under debate as to whether those organisms possess any sex hormones at all. The elaborated studies of sexual determination and differentiation mechanisms in Drosophila sp. favor the belief that these processes rely solely upon autonomous cellular differentiation mechanisms governed by the cascade of three genes. Contrary to the above is the steroidogenic effect of the gonadotropins of two locust species, the mosquito Aedes and the male gypsy moth Lymantria [21] . Thus, the absence of an underlying common effector for arthropods that triggers sexual differentiation and male reproductive physiology is puzzling.
Because M. rosenbergii is a commercially valuable commodity, the molecular novelties of the present study could result in a new crustacean monosex biotechnology. Our results provide a proof of concept for a biotechnology of crustacean monosex population culture based on AG-specific factor manipulation, primarily the IAG, which was recently identified in representative species of all four major cultured crustacean groups [22] [23] [24] , as well as on genomic sex markers that are also available for several species [5, 25] . Indeed, many of the gonochoristic cultured crustacean species are sexually dimorphic, making monosex culture a preferred technology [9, [26] [27] [28] to increase yields in this industry, which had an estimated annual value of more than $24 billion in 2009 [28] .
In terms of ecological significance, monosex population culture can serve as the first line of defense against dissemination of newly introduced species; because monosex populations are inherently nonbreeding, slippage of specimens to the wild will result in a limited, single-generation impact. Many crustacean species inflict ecological hazard as invasive species, cause losses to the economy, and damage human health and well-being due to their high invasiveness, and efforts to manage these species are yet to prove successful [8] . Sexual manipulation is a promising route, as has been successfully realized with eradication of insects where sterile male dissemination minimized the impact of the detrimental species [9] . Adopting sexual differentiation manipulation schemes through research avenues aiming to eradicate ecologically detrimental crustacean species [29] might, therefore, be a promising area of research for this field.
